Vor Biopharma Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vor Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Vor Biopharma Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$29M, a 9.76% increase year-over-year.
  • Vor Biopharma Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$125M, a 12% decline year-over-year.
  • Vor Biopharma Inc. annual Operating Income (Loss) for 2023 was -$126M, a 34.9% decline from 2022.
  • Vor Biopharma Inc. annual Operating Income (Loss) for 2022 was -$93.4M, a 35.4% decline from 2021.
  • Vor Biopharma Inc. annual Operating Income (Loss) for 2021 was -$69M, a 59.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$126M -$32.6M -34.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$93.4M -$24.4M -35.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$69M -$25.7M -59.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$43.4M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.